APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antimycobacterial Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Antimycobacterial Drugs Industry Growth and Trends Forecast to 2032

20 December 2025108 pages

Choose your research edition.

Industry ResearchAntimycobacterial Drugs Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Antimycobacterial Drugs Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Antimycobacterial Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antimycobacterial Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Antimycobacterial Drugs Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Antimycobacterial Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Antimycobacterial Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Antimycobacterial Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antimycobacterial Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antimycobacterial Drugs include Sanofi, Novartis, Merck, Pfizer, GlaxoSmithKline, Bayer, AstraZeneca, Zydus Cadila and Systopic Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Antimycobacterial Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antimycobacterial Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antimycobacterial Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antimycobacterial Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antimycobacterial Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antimycobacterial Drugs Market by Company

Sanofi

Novartis

Merck

Pfizer

GlaxoSmithKline

Bayer

AstraZeneca

Zydus Cadila

Systopic Laboratories

Macleods Pharmaceuticals

Lupin

Antimycobacterial Drugs Segment by Type

Drugs Used for Tuberculosis

Drugs Used for Leprosy

Drugs Used for Atypical Mycobacteria

Antimycobacterial Drugs Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Antimycobacterial Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antimycobacterial Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antimycobacterial Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antimycobacterial Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antimycobacterial Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antimycobacterial Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Drugs Used for Tuberculosis Table 2. Major Company of Drugs Used for Leprosy Table 3. Major Company of Drugs Used for Atypical Mycobacteria Table 4. Global Antimycobacterial Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Antimycobacterial Drugs Sales by Type (2021-2026) & (K Units) Table 6. Global Antimycobacterial Drugs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Antimycobacterial Drugs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Antimycobacterial Drugs Sales Market Share in Value by Type (2021-2026) Table 9. Global Antimycobacterial Drugs Price by Type (2021-2026) & (US$/Unit) Table 10. Global Antimycobacterial Drugs Sales by Type (2027-2032) & (K Units) Table 11. Global Antimycobacterial Drugs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Antimycobacterial Drugs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Antimycobacterial Drugs Sales Market Share in Value by Type (2027-2032) Table 14. Global Antimycobacterial Drugs Price by Type (2027-2032) & (US$/Unit) Table 15. North America Antimycobacterial Drugs Sales by Type (2021-2026) & (K Units) Table 16. North America Antimycobacterial Drugs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Antimycobacterial Drugs Sales by Type (2021-2026) & (K Units) Table 18. Europe Antimycobacterial Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Antimycobacterial Drugs Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Antimycobacterial Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Antimycobacterial Drugs Sales by Type (2021-2026) & (K Units) Table 22. Latin America Antimycobacterial Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Antimycobacterial Drugs Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Antimycobacterial Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Antimycobacterial Drugs Industry Trends Table 26. Antimycobacterial Drugs Industry Drivers Table 27. Antimycobacterial Drugs Industry Opportunities and Challenges Table 28. Antimycobacterial Drugs Industry Restraints Table 29. Global Antimycobacterial Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Antimycobacterial Drugs Revenue Market Share by Company (2021-2026) Table 31. Global Antimycobacterial Drugs Sales by Company (2021-2026) & (K Units) Table 32. Global Antimycobacterial Drugs Sales Share by Company (2021-2026) Table 33. Global Antimycobacterial Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Antimycobacterial Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Antimycobacterial Drugs Major Company Production Sites and Headquarters Table 36. Global Antimycobacterial Drugs Company, Product Type & Application Table 37. Global Antimycobacterial Drugs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Antimycobacterial Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Antimycobacterial Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Antimycobacterial Drugs Sales by Region (2021-2026) & (K Units) Table 42. Global Antimycobacterial Drugs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Antimycobacterial Drugs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Antimycobacterial Drugs Sales Market Share in Value by Region (2021-2026) Table 45. Global Antimycobacterial Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Antimycobacterial Drugs Sales by Region (2027-2032) & (K Units) Table 47. Global Antimycobacterial Drugs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Antimycobacterial Drugs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Antimycobacterial Drugs Sales Market Share in Value by Region (2027-2032) Table 50. Global Antimycobacterial Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Antimycobacterial Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Antimycobacterial Drugs Sales by Application (2021-2026) & (K Units) Table 53. Global Antimycobacterial Drugs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Antimycobacterial Drugs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Antimycobacterial Drugs Sales Market Share in Value by Application (2021-2026) Table 56. Global Antimycobacterial Drugs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Antimycobacterial Drugs Sales by Application (2027-2032) & (K Units) Table 58. Global Antimycobacterial Drugs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Antimycobacterial Drugs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Antimycobacterial Drugs Sales Market Share in Value by Application (2027-2032) Table 61. Global Antimycobacterial Drugs Price by Application (2027-2032) & (US$/Unit) Table 62. North America Antimycobacterial Drugs Sales by Application (2021-2026) & (K Units) Table 63. North America Antimycobacterial Drugs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Antimycobacterial Drugs Sales by Application (2021-2026) & (K Units) Table 65. Europe Antimycobacterial Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Antimycobacterial Drugs Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Antimycobacterial Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Antimycobacterial Drugs Sales by Application (2021-2026) & (K Units) Table 69. Latin America Antimycobacterial Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Antimycobacterial Drugs Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Antimycobacterial Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Sanofi Company Information Table 73. Sanofi Business Overview Table 74. Sanofi Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Sanofi Antimycobacterial Drugs Product Portfolio Table 76. Sanofi Recent Development Table 77. Novartis Company Information Table 78. Novartis Business Overview Table 79. Novartis Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Novartis Antimycobacterial Drugs Product Portfolio Table 81. Novartis Recent Development Table 82. Merck Company Information Table 83. Merck Business Overview Table 84. Merck Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Merck Antimycobacterial Drugs Product Portfolio Table 86. Merck Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Pfizer Antimycobacterial Drugs Product Portfolio Table 91. Pfizer Recent Development Table 92. GlaxoSmithKline Company Information Table 93. GlaxoSmithKline Business Overview Table 94. GlaxoSmithKline Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. GlaxoSmithKline Antimycobacterial Drugs Product Portfolio Table 96. GlaxoSmithKline Recent Development Table 97. Bayer Company Information Table 98. Bayer Business Overview Table 99. Bayer Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Bayer Antimycobacterial Drugs Product Portfolio Table 101. Bayer Recent Development Table 102. AstraZeneca Company Information Table 103. AstraZeneca Business Overview Table 104. AstraZeneca Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. AstraZeneca Antimycobacterial Drugs Product Portfolio Table 106. AstraZeneca Recent Development Table 107. Zydus Cadila Company Information Table 108. Zydus Cadila Business Overview Table 109. Zydus Cadila Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Zydus Cadila Antimycobacterial Drugs Product Portfolio Table 111. Zydus Cadila Recent Development Table 112. Systopic Laboratories Company Information Table 113. Systopic Laboratories Business Overview Table 114. Systopic Laboratories Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Systopic Laboratories Antimycobacterial Drugs Product Portfolio Table 116. Systopic Laboratories Recent Development Table 117. Macleods Pharmaceuticals Company Information Table 118. Macleods Pharmaceuticals Business Overview Table 119. Macleods Pharmaceuticals Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Macleods Pharmaceuticals Antimycobacterial Drugs Product Portfolio Table 121. Macleods Pharmaceuticals Recent Development Table 122. Lupin Company Information Table 123. Lupin Business Overview Table 124. Lupin Antimycobacterial Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Lupin Antimycobacterial Drugs Product Portfolio Table 126. Lupin Recent Development Table 127. North America Antimycobacterial Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. North America Antimycobacterial Drugs Sales by Country (2021-2026) & (K Units) Table 129. North America Antimycobacterial Drugs Sales Market Share by Country (2021-2026) Table 130. North America Antimycobacterial Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 131. North America Antimycobacterial Drugs Sales Market Share Forecast by Country (2027-2032) Table 132. North America Antimycobacterial Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Antimycobacterial Drugs Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Antimycobacterial Drugs Market Share by Country (2021-2026) Table 135. North America Antimycobacterial Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Antimycobacterial Drugs Market Share Forecast by Country (2027-2032) Table 137. Europe Antimycobacterial Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Europe Antimycobacterial Drugs Sales by Country (2021-2026) & (K Units) Table 139. Europe Antimycobacterial Drugs Sales Market Share by Country (2021-2026) Table 140. Europe Antimycobacterial Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 141. Europe Antimycobacterial Drugs Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Antimycobacterial Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Antimycobacterial Drugs Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Antimycobacterial Drugs Market Share by Country (2021-2026) Table 145. Europe Antimycobacterial Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Antimycobacterial Drugs Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Antimycobacterial Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Antimycobacterial Drugs Sales by Country (2021-2026) & (K Units) Table 149. Asia-Pacific Antimycobacterial Drugs Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Antimycobacterial Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 151. Asia-Pacific Antimycobacterial Drugs Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Antimycobacterial Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Antimycobacterial Drugs Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Antimycobacterial Drugs Market Share by Country (2021-2026) Table 155. Asia-Pacific Antimycobacterial Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Antimycobacterial Drugs Market Share Forecast by Country (2027-2032) Table 157. Latin America Antimycobacterial Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Latin America Antimycobacterial Drugs Sales by Country (2021-2026) & (K Units) Table 159. Latin America Antimycobacterial Drugs Sales Market Share by Country (2021-2026) Table 160. Latin America Antimycobacterial Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 161. Latin America Antimycobacterial Drugs Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Antimycobacterial Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Antimycobacterial Drugs Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Antimycobacterial Drugs Market Share by Country (2021-2026) Table 165. Latin America Antimycobacterial Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Antimycobacterial Drugs Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Antimycobacterial Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Antimycobacterial Drugs Sales by Country (2021-2026) & (K Units) Table 169. Middle East and Africa Antimycobacterial Drugs Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Antimycobacterial Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 171. Middle East and Africa Antimycobacterial Drugs Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Antimycobacterial Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Antimycobacterial Drugs Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Antimycobacterial Drugs Market Share by Country (2021-2026) Table 175. Middle East and Africa Antimycobacterial Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Antimycobacterial Drugs Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Antimycobacterial Drugs Distributors List Table 180. Antimycobacterial Drugs Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Antimycobacterial Drugs Image Figure 2. Global Antimycobacterial Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antimycobacterial Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Antimycobacterial Drugs Sales (2021-2032) & (K Units) Figure 5. Drugs Used for Tuberculosis Image Figure 6. Global Drugs Used for Tuberculosis Sales YoY Growth (2021-2032) & (K Units) Figure 7. Drugs Used for Leprosy Image Figure 8. Global Drugs Used for Leprosy Sales YoY Growth (2021-2032) & (K Units) Figure 9. Drugs Used for Atypical Mycobacteria Image Figure 10. Global Drugs Used for Atypical Mycobacteria Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Antimycobacterial Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Antimycobacterial Drugs Market Share by Type 2025 VS 2032 Figure 13. North America Antimycobacterial Drugs Sales Market Share in Volume by Type in 2025 Figure 14. North America Antimycobacterial Drugs Sales Market Share in Value by Type in 2025 Figure 15. Europe Antimycobacterial Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Antimycobacterial Drugs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Antimycobacterial Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Antimycobacterial Drugs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Antimycobacterial Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Antimycobacterial Drugs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Antimycobacterial Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Antimycobacterial Drugs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Antimycobacterial Drugs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Retail Pharmacies Image Figure 26. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 27. Online Pharmacies Image Figure 28. Global Online Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 29. Hospital Pharmacies Image Figure 30. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Antimycobacterial Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Antimycobacterial Drugs Market Share by Application 2025 VS 2032 Figure 33. North America Antimycobacterial Drugs Sales Market Share in Volume by Application in 2025 Figure 34. North America Antimycobacterial Drugs Sales Market Share in Value by Application in 2025 Figure 35. Europe Antimycobacterial Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Europe Antimycobacterial Drugs Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Antimycobacterial Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Antimycobacterial Drugs Sales Market Share in Value by Application in 2025 Figure 39. Latin America Antimycobacterial Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Antimycobacterial Drugs Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Antimycobacterial Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Antimycobacterial Drugs Sales Market Share in Value by Application in 2025 Figure 43. North America Antimycobacterial Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Antimycobacterial Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Antimycobacterial Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Antimycobacterial Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Antimycobacterial Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Antimycobacterial Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Antimycobacterial Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Antimycobacterial Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Antimycobacterial Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Antimycobacterial Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Antimycobacterial Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Antimycobacterial Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Antimycobacterial Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Antimycobacterial Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Antimycobacterial Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Antimycobacterial Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Antimycobacterial Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Antimycobacterial Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Antimycobacterial Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Antimycobacterial Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Antimycobacterial Drugs Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Antimycobacterial Drugs Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Drugs Used for Tuberculosis
  • Drugs Used for Leprosy
  • Drugs Used for Atypical Mycobacteria
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Sanofi
  • Novartis
  • Merck
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • AstraZeneca
  • Zydus Cadila
  • Systopic Laboratories
  • Macleods Pharmaceuticals
  • Lupin

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antimycobacterial Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antimycobacterial Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antimycobacterial Drugs Market by Type
  6. 1.3.1 Drugs Used for Tuberculosis
  7. 1.3.2 Drugs Used for Leprosy
  8. 1.3.3 Drugs Used for Atypical Mycobacteria
  9. 1.4 Global Antimycobacterial Drugs Market Size by Type
  10. 1.4.1 Global Antimycobacterial Drugs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Antimycobacterial Drugs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Antimycobacterial Drugs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Antimycobacterial Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Antimycobacterial Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Antimycobacterial Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Antimycobacterial Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Antimycobacterial Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antimycobacterial Drugs Industry Trends
  2. 2.2 Antimycobacterial Drugs Industry Drivers
  3. 2.3 Antimycobacterial Drugs Industry Opportunities and Challenges
  4. 2.4 Antimycobacterial Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antimycobacterial Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Antimycobacterial Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Antimycobacterial Drugs Price (2021-2026)
  4. 3.4 Global Antimycobacterial Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antimycobacterial Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Antimycobacterial Drugs Company, Product Type & Application
  7. 3.7 Global Antimycobacterial Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antimycobacterial Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antimycobacterial Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antimycobacterial Drugs Tier 1, Tier 2, and Tier 3
4 Antimycobacterial Drugs Regional Status and Outlook
  1. 4.1 Global Antimycobacterial Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antimycobacterial Drugs Historic Market Size by Region
  3. 4.2.1 Global Antimycobacterial Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antimycobacterial Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antimycobacterial Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antimycobacterial Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Antimycobacterial Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antimycobacterial Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antimycobacterial Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antimycobacterial Drugs by Application
  1. 5.1 Antimycobacterial Drugs Market by Application
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Antimycobacterial Drugs Market Size by Application
  6. 5.2.1 Global Antimycobacterial Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Antimycobacterial Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Antimycobacterial Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Antimycobacterial Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Antimycobacterial Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Antimycobacterial Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Antimycobacterial Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Antimycobacterial Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Antimycobacterial Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Antimycobacterial Drugs Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Antimycobacterial Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Antimycobacterial Drugs Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Antimycobacterial Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Antimycobacterial Drugs Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Antimycobacterial Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Antimycobacterial Drugs Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 GlaxoSmithKline
  26. 6.5.1 GlaxoSmithKline Company Information
  27. 6.5.2 GlaxoSmithKline Business Overview
  28. 6.5.3 GlaxoSmithKline Antimycobacterial Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 GlaxoSmithKline Antimycobacterial Drugs Product Portfolio
  30. 6.5.5 GlaxoSmithKline Recent Developments
  31. 6.6 Bayer
  32. 6.6.1 Bayer Company Information
  33. 6.6.2 Bayer Business Overview
  34. 6.6.3 Bayer Antimycobacterial Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bayer Antimycobacterial Drugs Product Portfolio
  36. 6.6.5 Bayer Recent Developments
  37. 6.7 AstraZeneca
  38. 6.7.1 AstraZeneca Company Information
  39. 6.7.2 AstraZeneca Business Overview
  40. 6.7.3 AstraZeneca Antimycobacterial Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 AstraZeneca Antimycobacterial Drugs Product Portfolio
  42. 6.7.5 AstraZeneca Recent Developments
  43. 6.8 Zydus Cadila
  44. 6.8.1 Zydus Cadila Company Information
  45. 6.8.2 Zydus Cadila Business Overview
  46. 6.8.3 Zydus Cadila Antimycobacterial Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Zydus Cadila Antimycobacterial Drugs Product Portfolio
  48. 6.8.5 Zydus Cadila Recent Developments
  49. 6.9 Systopic Laboratories
  50. 6.9.1 Systopic Laboratories Company Information
  51. 6.9.2 Systopic Laboratories Business Overview
  52. 6.9.3 Systopic Laboratories Antimycobacterial Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Systopic Laboratories Antimycobacterial Drugs Product Portfolio
  54. 6.9.5 Systopic Laboratories Recent Developments
  55. 6.10 Macleods Pharmaceuticals
  56. 6.10.1 Macleods Pharmaceuticals Company Information
  57. 6.10.2 Macleods Pharmaceuticals Business Overview
  58. 6.10.3 Macleods Pharmaceuticals Antimycobacterial Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Macleods Pharmaceuticals Antimycobacterial Drugs Product Portfolio
  60. 6.10.5 Macleods Pharmaceuticals Recent Developments
  61. 6.11 Lupin
  62. 6.11.1 Lupin Company Information
  63. 6.11.2 Lupin Business Overview
  64. 6.11.3 Lupin Antimycobacterial Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Lupin Antimycobacterial Drugs Product Portfolio
  66. 6.11.5 Lupin Recent Developments
7 North America by Country
  1. 7.1 North America Antimycobacterial Drugs Sales by Country
  2. 7.1.1 North America Antimycobacterial Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antimycobacterial Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Antimycobacterial Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antimycobacterial Drugs Market Size by Country
  6. 7.2.1 North America Antimycobacterial Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antimycobacterial Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Antimycobacterial Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antimycobacterial Drugs Sales by Country
  2. 8.1.1 Europe Antimycobacterial Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antimycobacterial Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Antimycobacterial Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antimycobacterial Drugs Market Size by Country
  6. 8.2.1 Europe Antimycobacterial Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antimycobacterial Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antimycobacterial Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antimycobacterial Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Antimycobacterial Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antimycobacterial Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antimycobacterial Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antimycobacterial Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Antimycobacterial Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antimycobacterial Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antimycobacterial Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antimycobacterial Drugs Sales by Country
  2. 10.1.1 South America Antimycobacterial Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antimycobacterial Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Antimycobacterial Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antimycobacterial Drugs Market Size by Country
  6. 10.2.1 South America Antimycobacterial Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antimycobacterial Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Antimycobacterial Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antimycobacterial Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Antimycobacterial Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antimycobacterial Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antimycobacterial Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antimycobacterial Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Antimycobacterial Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antimycobacterial Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antimycobacterial Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antimycobacterial Drugs Value Chain Analysis
  2. 12.1.1 Antimycobacterial Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antimycobacterial Drugs Production Mode & Process
  7. 12.2 Antimycobacterial Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antimycobacterial Drugs Distributors
  10. 12.2.3 Antimycobacterial Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst